S&P 500   4,270.96 (-0.07%)
DOW   33,876.15 (-0.31%)
QQQ   329.08 (+0.18%)
AAPL   174.07 (-0.27%)
MSFT   290.50 (-0.28%)
META   174.52 (-0.19%)
GOOGL   119.96 (+0.34%)
AMZN   142.02 (-0.06%)
TSLA   912.37 (+0.04%)
NVDA   187.11 (+2.05%)
NIO   19.90 (-0.90%)
BABA   90.49 (+0.80%)
AMD   100.38 (+2.15%)
MU   62.84 (+1.98%)
T   18.42 (+0.00%)
CGC   3.80 (-6.40%)
F   16.00 (-0.19%)
GE   79.31 (-0.76%)
DIS   122.31 (-0.41%)
AMC   20.12 (-5.81%)
PYPL   98.63 (-0.79%)
PFE   48.57 (-1.42%)
NFLX   245.04 (+1.61%)
S&P 500   4,270.96 (-0.07%)
DOW   33,876.15 (-0.31%)
QQQ   329.08 (+0.18%)
AAPL   174.07 (-0.27%)
MSFT   290.50 (-0.28%)
META   174.52 (-0.19%)
GOOGL   119.96 (+0.34%)
AMZN   142.02 (-0.06%)
TSLA   912.37 (+0.04%)
NVDA   187.11 (+2.05%)
NIO   19.90 (-0.90%)
BABA   90.49 (+0.80%)
AMD   100.38 (+2.15%)
MU   62.84 (+1.98%)
T   18.42 (+0.00%)
CGC   3.80 (-6.40%)
F   16.00 (-0.19%)
GE   79.31 (-0.76%)
DIS   122.31 (-0.41%)
AMC   20.12 (-5.81%)
PYPL   98.63 (-0.79%)
PFE   48.57 (-1.42%)
NFLX   245.04 (+1.61%)
S&P 500   4,270.96 (-0.07%)
DOW   33,876.15 (-0.31%)
QQQ   329.08 (+0.18%)
AAPL   174.07 (-0.27%)
MSFT   290.50 (-0.28%)
META   174.52 (-0.19%)
GOOGL   119.96 (+0.34%)
AMZN   142.02 (-0.06%)
TSLA   912.37 (+0.04%)
NVDA   187.11 (+2.05%)
NIO   19.90 (-0.90%)
BABA   90.49 (+0.80%)
AMD   100.38 (+2.15%)
MU   62.84 (+1.98%)
T   18.42 (+0.00%)
CGC   3.80 (-6.40%)
F   16.00 (-0.19%)
GE   79.31 (-0.76%)
DIS   122.31 (-0.41%)
AMC   20.12 (-5.81%)
PYPL   98.63 (-0.79%)
PFE   48.57 (-1.42%)
NFLX   245.04 (+1.61%)
S&P 500   4,270.96 (-0.07%)
DOW   33,876.15 (-0.31%)
QQQ   329.08 (+0.18%)
AAPL   174.07 (-0.27%)
MSFT   290.50 (-0.28%)
META   174.52 (-0.19%)
GOOGL   119.96 (+0.34%)
AMZN   142.02 (-0.06%)
TSLA   912.37 (+0.04%)
NVDA   187.11 (+2.05%)
NIO   19.90 (-0.90%)
BABA   90.49 (+0.80%)
AMD   100.38 (+2.15%)
MU   62.84 (+1.98%)
T   18.42 (+0.00%)
CGC   3.80 (-6.40%)
F   16.00 (-0.19%)
GE   79.31 (-0.76%)
DIS   122.31 (-0.41%)
AMC   20.12 (-5.81%)
PYPL   98.63 (-0.79%)
PFE   48.57 (-1.42%)
NFLX   245.04 (+1.61%)
NYSE:USPH

U.S. Physical Therapy - USPH Stock Forecast, Price & News

$84.04
+0.55 (+0.66%)
(As of 08/18/2022 12:18 PM ET)
Add
Compare
Today's Range
$83.11
$84.51
50-Day Range
$83.49
$130.18
52-Week Range
$81.72
$131.50
Volume
1,076 shs
Average Volume
118,697 shs
Market Capitalization
$1.09 billion
P/E Ratio
28.68
Dividend Yield
1.87%
Price Target
$121.50

U.S. Physical Therapy MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
44.6% Upside
$121.50 Price Target
Short Interest
Bearish
5.50% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
0.21mentions of U.S. Physical Therapy in the last 14 days
Based on 7 Articles This Week
Insider Trading
Selling Shares
$515,670 Sold Last Quarter
Proj. Earnings Growth
11.11%
From $2.70 to $3.00 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.91 out of 5 stars

Medical Sector

40th out of 1,122 stocks

Health Services Industry

1st out of 12 stocks

USPH stock logo

About U.S. Physical Therapy (NYSE:USPH) Stock

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.

U.S. Physical Therapy Stock Performance

Shares of NYSE:USPH traded up $0.57 during midday trading on Thursday, hitting $84.06. The company had a trading volume of 620 shares, compared to its average volume of 118,697. The company has a market cap of $1.09 billion, a price-to-earnings ratio of 28.49 and a beta of 1.22. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.43 and a quick ratio of 1.43. The company has a fifty day moving average of $110.97 and a two-hundred day moving average of $104.54. U.S. Physical Therapy has a 12-month low of $81.72 and a 12-month high of $131.50.

U.S. Physical Therapy (NYSE:USPH - Get Rating) last posted its quarterly earnings data on Thursday, August 4th. The company reported $0.90 EPS for the quarter, missing the consensus estimate of $0.93 by ($0.03). The company had revenue of $140.70 million during the quarter, compared to the consensus estimate of $143.01 million. U.S. Physical Therapy had a return on equity of 14.22% and a net margin of 7.62%. The firm's quarterly revenue was up 10.9% compared to the same quarter last year. During the same period last year, the business earned $0.96 EPS. On average, equities research analysts expect that U.S. Physical Therapy will post 2.7 EPS for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, September 16th. Investors of record on Thursday, August 18th will be issued a $0.41 dividend. This represents a $1.64 annualized dividend and a yield of 1.95%. The ex-dividend date is Wednesday, August 17th. U.S. Physical Therapy's dividend payout ratio is currently 55.97%.

Analysts Set New Price Targets

Separately, TheStreet raised U.S. Physical Therapy from a "c+" rating to a "b-" rating in a research report on Thursday, July 28th.

Insiders Place Their Bets

In related news, Director Anne Motsenbocker bought 500 shares of the business's stock in a transaction that occurred on Tuesday, August 9th. The stock was bought at an average cost of $92.29 per share, with a total value of $46,145.00. Following the completion of the purchase, the director now owns 2,600 shares of the company's stock, valued at approximately $239,954. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, Director Anne Motsenbocker acquired 500 shares of the business's stock in a transaction on Tuesday, August 9th. The shares were acquired at an average price of $92.29 per share, for a total transaction of $46,145.00. Following the completion of the transaction, the director now directly owns 2,600 shares of the company's stock, valued at approximately $239,954. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Richard Binstein sold 1,808 shares of the business's stock in a transaction dated Thursday, August 11th. The shares were sold at an average price of $90.43, for a total transaction of $163,497.44. Following the completion of the sale, the executive vice president now directly owns 7,971 shares of the company's stock, valued at $720,817.53. The disclosure for this sale can be found here. 1.90% of the stock is currently owned by company insiders.

Receive USPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for U.S. Physical Therapy and its competitors with MarketBeat's FREE daily newsletter.

USPH Stock News Headlines

U.S. Physical Therapy (NYSE:USPH) Lifted to "B-" at TheStreet
U.S. Physical Therapy: Outpatient Pure Play
See More Headlines
Receive USPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for U.S. Physical Therapy and its competitors with MarketBeat's FREE daily newsletter.

USPH Company Calendar

Ex-Dividend for 6/14 Dividend
5/13/2022
Dividend Payable
6/14/2022
Last Earnings
8/04/2022
Ex-Dividend for 9/16 Dividend
8/17/2022
Today
8/18/2022
Dividend Payable
9/16/2022
Next Earnings (Estimated)
11/03/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Health services
Sub-Industry
Health Care Facilities
Sector
Medical
CUSIP
90337L10
Employees
5,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$121.50
High Stock Price Forecast
$123.00
Low Stock Price Forecast
$120.00
Forecasted Upside/Downside
+44.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$40.83 million
Pretax Margin
13.50%

Debt

Sales & Book Value

Annual Sales
$495.02 million
Cash Flow
$4.63 per share
Book Value
$23.76 per share

Miscellaneous

Free Float
12,757,000
Market Cap
$1.09 billion
Optionable
Optionable
Beta
1.22

Key Executives














USPH Stock - Frequently Asked Questions

Should I buy or sell U.S. Physical Therapy stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" USPH shares.
View USPH analyst ratings
or view top-rated stocks.

What is U.S. Physical Therapy's stock price forecast for 2022?

2 equities research analysts have issued 1 year price targets for U.S. Physical Therapy's stock. Their USPH share price forecasts range from $120.00 to $123.00. On average, they predict the company's stock price to reach $121.50 in the next year. This suggests a possible upside of 45.5% from the stock's current price.
View analysts price targets for USPH
or view top-rated stocks among Wall Street analysts.

How have USPH shares performed in 2022?

U.S. Physical Therapy's stock was trading at $95.55 at the beginning of 2022. Since then, USPH shares have decreased by 12.6% and is now trading at $83.49.
View the best growth stocks for 2022 here
.

When is U.S. Physical Therapy's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our USPH earnings forecast
.

How were U.S. Physical Therapy's earnings last quarter?

U.S. Physical Therapy, Inc. (NYSE:USPH) posted its earnings results on Thursday, August, 4th. The company reported $0.90 EPS for the quarter, missing the consensus estimate of $0.93 by $0.03. The business earned $140.70 million during the quarter, compared to analysts' expectations of $143.01 million. U.S. Physical Therapy had a net margin of 7.62% and a trailing twelve-month return on equity of 14.22%. The firm's quarterly revenue was up 10.9% on a year-over-year basis. During the same quarter last year, the firm posted $0.96 EPS.

How often does U.S. Physical Therapy pay dividends? What is the dividend yield for U.S. Physical Therapy?

U.S. Physical Therapy declared a quarterly dividend on Thursday, August 4th. Stockholders of record on Thursday, August 18th will be given a dividend of $0.41 per share on Friday, September 16th. This represents a $1.64 dividend on an annualized basis and a dividend yield of 1.96%. The ex-dividend date is Wednesday, August 17th.
Read our dividend analysis for USPH
.

Is U.S. Physical Therapy a good dividend stock?

U.S. Physical Therapy (NYSE:USPH) pays an annual dividend of $1.64 per share and currently has a dividend yield of 1.87%. The company has been increasing its dividend for 3 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 55.97%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, USPH will have a dividend payout ratio of 54.67% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for USPH.

What guidance has U.S. Physical Therapy issued on next quarter's earnings?

U.S. Physical Therapy issued an update on its FY 2022 earnings guidance on Thursday, August, 18th. The company provided EPS guidance of $2.65-$2.75 for the period. The company issued revenue guidance of -.

What is Chris Reading's approval rating as U.S. Physical Therapy's CEO?

38 employees have rated U.S. Physical Therapy Chief Executive Officer Chris Reading on Glassdoor.com. Chris Reading has an approval rating of 49% among the company's employees. This puts Chris Reading in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of U.S. Physical Therapy own?

Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Physical Therapy investors own include Pfizer (PFE), NVIDIA (NVDA), AbbVie (ABBV), CVS Health (CVS), Gilead Sciences (GILD), International Business Machines (IBM), Illumina (ILMN), Johnson & Johnson (JNJ), Lowe's Companies (LOW) and Marathon Petroleum (MPC).

What is U.S. Physical Therapy's stock symbol?

U.S. Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "USPH."

Who are U.S. Physical Therapy's major shareholders?

U.S. Physical Therapy's stock is owned by many different retail and institutional investors. Top institutional investors include Kayne Anderson Rudnick Investment Management LLC (11.61%), Price T Rowe Associates Inc. MD (9.57%), Copeland Capital Management LLC (3.99%), State Street Corp (3.56%), Boston Trust Walden Corp (3.50%) and Riverbridge Partners LLC (3.31%). Insiders that own company stock include Anne Motsenbocker, Bernard A Harris Jr, Bernard A Harris, Jr, Christopher J Reading, Christopher J Reading, Edward L Kuntz, Eric Joseph Williams, Glenn Mcdowell, Graham D Reeve, Graham D Reeve, Harry S Chapman, Harry S Chapman, Kathleen A Gilmartin, Lawrance W Mcafee, Mark J Brookner, Regg E Swanson and Richard Binstein.
View institutional ownership trends
.

How do I buy shares of U.S. Physical Therapy?

Shares of USPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is U.S. Physical Therapy's stock price today?

One share of USPH stock can currently be purchased for approximately $83.49.

How much money does U.S. Physical Therapy make?

U.S. Physical Therapy (NYSE:USPH) has a market capitalization of $1.09 billion and generates $495.02 million in revenue each year. The company earns $40.83 million in net income (profit) each year or $2.93 on an earnings per share basis.

How many employees does U.S. Physical Therapy have?

The company employs 5,500 workers across the globe.

How can I contact U.S. Physical Therapy?

U.S. Physical Therapy's mailing address is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. The official website for the company is www.usph.com. The company can be reached via phone at (713) 297-7000, via email at lmcafee@usph.com, or via fax at 713-297-7090.

This page (NYSE:USPH) was last updated on 8/18/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.